MedTrace Logo

Apheresis Collection for New Drug Development and Evaluation Research

NCT07663565 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-06-23

No results posted yet for this study

Summary

Peripheral Blood Mononuclear Cells (PBMC) are a mixed population of cells with a single nucleus found in peripheral blood (i.e., blood outside the bone marrow), including natural killer cells (NK), T lymphocytes (70% - 90%), and B lymphocytes. They can be further isolated and purified and are the main source of immune cells. This study will be conducted at our hospital, with a planned recruitment of 200 subjects. Subjects who meet the inclusion criteria and do not meet the exclusion criteria will have their peripheral blood mononuclear cells collected via apheresis. Each subject will need to provide an apheresis sample containing approximately 8×10\^9 mononuclear cells (with a sample volume of about 150 mL).

Conditions

  • PBMCs

Interventions

OTHER

None AHT

No intervention measures

Sponsors & Collaborators

  • TCRx Therapeutics Co.Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-22
Primary Completion
2028-06-21
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07663565 on ClinicalTrials.gov